6339 related articles for article (PubMed ID: 14533809)
1. Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines.
Hakomori S
Adv Exp Med Biol; 2001; 491():369-402. PubMed ID: 14533809
[TBL] [Abstract][Full Text] [Related]
2. Cancer vaccines and carbohydrate epitopes.
Heimburg-Molinaro J; Lum M; Vijay G; Jain M; Almogren A; Rittenhouse-Olson K
Vaccine; 2011 Nov; 29(48):8802-26. PubMed ID: 21964054
[TBL] [Abstract][Full Text] [Related]
3. Traveling for the glycosphingolipid path.
Hakomori S
Glycoconj J; 2000; 17(7-9):627-47. PubMed ID: 11421354
[TBL] [Abstract][Full Text] [Related]
4. [Gangliosides as carbohydrate antigens associated with cancer and their possible use in tumor immunotherapy].
Horwacik I
Przegl Lek; 2004; 61 Suppl 2():14-9. PubMed ID: 15686040
[TBL] [Abstract][Full Text] [Related]
5. Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers.
Zhang S; Zhang HS; Reuter VE; Slovin SF; Scher HI; Livingston PO
Clin Cancer Res; 1998 Feb; 4(2):295-302. PubMed ID: 9516914
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy.
Springer GF
J Mol Med (Berl); 1997 Aug; 75(8):594-602. PubMed ID: 9297627
[TBL] [Abstract][Full Text] [Related]
7. Recent Advance in Tumor-associated Carbohydrate Antigens (TACAs)-based Antitumor Vaccines.
Feng D; Shaikh AS; Wang F
ACS Chem Biol; 2016 Apr; 11(4):850-63. PubMed ID: 26895482
[TBL] [Abstract][Full Text] [Related]
8. Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens.
Zhang S; Zhang HS; Cordon-Cardo C; Reuter VE; Singhal AK; Lloyd KO; Livingston PO
Int J Cancer; 1997 Sep; 73(1):50-6. PubMed ID: 9334809
[TBL] [Abstract][Full Text] [Related]
9. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
Hakomori S
Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
[TBL] [Abstract][Full Text] [Related]
10. Antigen-specific vaccines for cancer treatment.
Tagliamonte M; Petrizzo A; Tornesello ML; Buonaguro FM; Buonaguro L
Hum Vaccin Immunother; 2014; 10(11):3332-46. PubMed ID: 25483639
[TBL] [Abstract][Full Text] [Related]
11. Recent development in carbohydrate-based cancer vaccines.
Guo Z; Wang Q
Curr Opin Chem Biol; 2009 Dec; 13(5-6):608-17. PubMed ID: 19766052
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated O-glycans of MUC1: Carriers of the glyco-code and targets for cancer vaccine design.
Beckwith DM; Cudic M
Semin Immunol; 2020 Feb; 47():101389. PubMed ID: 31926647
[TBL] [Abstract][Full Text] [Related]
13. Towards the development of peptide mimotopes of carbohydrate antigens as cancer vaccines.
Qiu J; Luo P; Wasmund K; Steplewski Z; Kieber-Emmons T
Hybridoma; 1999 Feb; 18(1):103-12. PubMed ID: 10211797
[TBL] [Abstract][Full Text] [Related]
14. Carbohydrate antigens as targets for active specific immunotherapy.
Ragupathi G
Cancer Immunol Immunother; 1996 Nov; 43(3):152-7. PubMed ID: 9001568
[TBL] [Abstract][Full Text] [Related]
15. Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives.
Berois N; Pittini A; Osinaga E
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158915
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of the density of cell surface carbohydrate antigens on cancer cells with a sensitive cell-suspension ELISA.
Ravindranath MH; Bauer PM; Cornillez-Ty C; Garcia J; Morton DL
J Immunol Methods; 1996 Oct; 197(1-2):51-67. PubMed ID: 8890894
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated carbohydrate antigens of MUC1 - Implication in cancer development.
Radziejewska I
Biomed Pharmacother; 2024 May; 174():116619. PubMed ID: 38643541
[TBL] [Abstract][Full Text] [Related]
18. Tn antigen analogues: the synthetic way to "upgrade" an attracting tumour associated carbohydrate antigen (TACA).
Nativi C; Papi F; Roelens S
Chem Commun (Camb); 2019 Jul; 55(54):7729-7736. PubMed ID: 31225574
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
